Latest filing published 05 Jun 2023 for Cara Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Harrison M. Bains Jr.: trading record in brief
Harrison M. Bains Jr. (board member) discloses dealings in Tvardi Therapeutics, Inc. to SEC (Form 4). We count 6 filings; the first trade dates from 4 June 2019 and the latest from 1 June 2023.
The open-market record consists of 1 sale worth €65k, with no purchase. The rest of the record consists of 5 share grants.
The record was last updated on 5 June 2023 with a share grant in Tvardi Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Harrison M. Bains Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 32,362 shares0Common StockSEC:0001209191-23-034322:0
- 7,200 shares@ US$9.05100.0% of flowCommon StockSEC:0001209191-22-042604:0
- 11,876 shares0Common StockSEC:0001209191-22-034625:0
- 7,200 shares0Common StockSEC:0001209191-21-038759:0
4 of 4 declarations